What is startup show?

A startup show is a public format—an event, demo day, competition, or online series—where startups present their product and business to an audience that typically includes investors, customers, partners, and press. The “show” part matters: it’s designed to be time-boxed, attention-grabbing, and comparable across companies (same stage, same rules, same judging criteria).

In medtech, a startup show is less about flashy storytelling and more about proving you understand clinical workflow, regulatory pathway, and reimbursement. A strong medtech “show” presentation answers: Who uses it? Who pays? What evidence exists or will exist? How will a hospital buy it?

What counts as a startup show (and what doesn’t)

People use “startup show” loosely. Here are the common formats:

• Demo day: A cohort (accelerator/incubator) presents short pitches to investors and industry. Usually 3–7 minutes plus Q&A.
• Pitch competition: Startups compete for prizes, pilots, or visibility. Often judged by investors, clinicians, and executives.
• Startup showcase/expo: Booth-style demos at conferences (e.g., a “startup pavilion”). Less stage time, more 1:1 conversations.
• Online startup show: Recorded or live streamed pitches/interviews (think “Shark Tank”-like, but often B2B). The goal is distribution and lead generation.

What doesn’t count: a normal sales meeting, a scientific poster session, or a regulatory pre-sub meeting. Those are important, but they’re not designed as a comparative “show” with a broad audience.

Why medtech founders should care: it’s a shortcut to signal

Early-stage medtech has a trust problem: buyers and investors can’t easily validate claims from a slide deck. A startup show creates signal—a credible hint that you’re worth deeper diligence—because it concentrates attention and social proof (selection into an accelerator, being chosen to pitch, winning a category, etc.).

But the signal only helps if your content matches medtech reality. A general-tech pitch that focuses on “TAM” (total addressable market) and “growth” without addressing FDA pathway, clinical evidence, and reimbursement can backfire: it tells the room you haven’t done the homework.

Typical medtech audiences at a startup show

• Investors: want risk reduction milestones (regulatory, clinical, commercial).
• Clinicians: want workflow fit, safety, and outcomes.
• Hospital stakeholders: procurement, value analysis, IT/security, and department leadership want budget impact and implementation clarity.
• Strategics (large medtech): want category fit and acquisition/partnership logic.

What a “good” medtech startup show pitch includes

Most startup shows give you very little time. Your job is to compress the business into a few testable claims and the next milestone. A practical structure:

1. Clinical problem + who feels the pain: Name the setting (ED, cath lab, ICU, outpatient) and the user (nurse, surgeon, tech). Avoid vague “healthcare is broken.”
2. Solution + demo: Show the product in the workflow. If it’s software, show the screen where the decision happens. If it’s a device, show the setup and the “moment of value.”
3. Evidence plan: What data do you have (bench, retrospective, pilot) and what’s next (prospective study, endpoints)? If human subjects are involved, mention IRB approval (Institutional Review Board) as part of the plan/timeline.
4. Regulatory pathway: State the likely route—510(k) (substantial equivalence), De Novo (novel low/moderate risk), or PMA (high risk)—and what that implies for time, evidence, and cost (details vary).
5. Reimbursement / payment: If applicable, explain whether you rely on existing CPT codes (billing codes used for physician services) or a different payment model (hospital budget, DRG impact, subscription). If you don’t know yet, say so and describe your validation plan.
6. Go-to-market: Who buys first (department, hospital system, payer)? How do you get through hospital procurement and value analysis? What’s the first wedge use case?
7. Traction: Letters of intent, pilots, design partners, paid trials, or clear usage metrics. In medtech, “we talked to 50 doctors” is good discovery, not traction.
8. Ask: Money, pilots, distribution partners, clinical sites—be specific.

How startup shows differ for devices vs digital health

“Medtech” includes very different businesses. Tailor your show narrative accordingly.

Medical devices (hardware, implants, instruments)

• Risk and pathway dominate: investors will ask 510(k) vs De Novo vs PMA and what evidence you need.
• Manufacturing and quality matter early: design controls, verification/validation, and supply chain readiness become part of credibility.
• Adoption: training burden, sterile processing, capital vs disposable economics, and integration into OR/clinic flow.

Digital health (software, AI, remote monitoring)

• Clinical workflow + integration: EHR integration, alert fatigue, and who acts on the insight.
• Regulatory may still apply: some software is regulated as Software as a Medical Device; be prepared to explain your stance and plan.
• Security and compliance: hospital IT will care about data handling and implementation effort.
• Payment model: subscription, per-member-per-month, per-use, or budget impact; reimbursement may be indirect.

Common mistakes at medtech startup shows (and how to avoid them)

• Over-claiming outcomes: If you don’t have clinical evidence yet, don’t imply you do. Say “hypothesis” and outline the study.
• Skipping the buyer: “Hospitals will buy this” is not a plan. Name the economic buyer and the approval path (value analysis, procurement, IT).
• Confusing users with payers: The clinician may love it, but the department budget (or payer) decides. Address both.
• Regulatory hand-waving: “FDA later” is a red flag. Even a preliminary pathway view is better than none.
• No wedge: If your first use case is “all of cardiology,” you’ll look unfocused. Start with a narrow, high-value workflow.

What to do next

1. Write a 1-page “show pitch” that includes: user, buyer, evidence plan, regulatory pathway (510(k)/De Novo/PMA), and reimbursement approach (CPT/budget/other).
2. Build a 60-second demo that shows the exact workflow moment where value is created (not a feature tour).
3. Pre-answer diligence questions in a simple FAQ: regulatory, clinical study plan/IRB, procurement steps, and integration requirements.
4. Practice with a hostile Q&A: have a clinician, a hospital operator, and a “numbers person” challenge your assumptions.

If you want feedback on your pitch positioning and medtech business logic, run it through our tools and templates.